Back to search

University of Thessaly (UTH)

Η συγχορήγηση της ρανολαζίνης στην ταχύτητα ανάταξης της μετεγχειρητικής κολπικής μαρμαρυγής με αμιωδαρόνη σε ασθενείς μετά από αορτοστεφανιαία παράκαμψη

Abstract

dc:description

New postoperative atrial fibrillation occurs in a large proportion of patients (25-50%) undergoing aortic-coronary bypass. It may be short-lived or persistent and is associated with increased mortality and thromboembolic events. To date, many pharmaceutical interventions have been tried to prevent or convert it. Antiarrhythmic drugs such as amiodarone, but also β-blockers, statins, aldosterone or angiotensin II antagonists, and antioxidants have been tested as upstream therapy with relatively limited efficacy and clinical application.Amiodarone is the first choice antiarrhythmic drug to reverse atrial fibrillation. Unfortunately, acute intravenous administration of amiodarone often needs longer time to terminate the arrhythmia. For this reason, we chose to co-administer amiodarone with ranolazine, a new antianginal agent with a stronger atrial-selective Na+ blocking activity, to study the time and rates of postoperative atrial fibrillation conversion within 36 hours of onset of intravenous infusion.In a single-center, prospective, randomized, single-blind study, a total of 301 patients were enrolled with newly developed postoperative atrial fibrillation after coronary artery bypass surgery. Patients were classified into two groups according to the treatment regimen they took to terminate the arrhythmia, with a 1:1 distribution ratio for the two regimens. Randomization was done with amiodarone (150 patients) and with a combination of amiodarone-ranolazine (151 patients). Primary goals of the study were conversion rates of atrial fibrillation within 24 hours of onset of treatment, but more specifically was the determination of the time to conversion of arrhythmia after starting with either of the treatment protocols. In the amiodarone group, the conversion rate was only about 15% between 20-24 hours, while in the combination group it was 100% for approximately 10-13 hours after beginning with the administration. In particular, recovery of sinus rhythm was reached at 26.85 ± 2.85 hours with amiodarone alone, and at 12.23 ± 1.103 hours with amiodarone plus ranolazine (P <0.0001). A significant increase in P wave duration in surface electrocardiogram after conversion of arrhythmia, in patients receiving the amiodarone-ranolazine combination compared to those receiving only amiodarone, suggests slowing of atrial conduction as a possible mechanism for earlier conversion of atrial fibrillation.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Simopoulos, Vasileios
  • Σιμόπουλος, Βασίλειος

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42349

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Simopoulos, Vasileios; Σιμόπουλος, Βασίλειος. Η συγχορήγηση της ρανολαζίνης στην ταχύτητα ανάταξης της μετεγχειρητικής κολπικής μαρμαρυγής με αμιωδαρόνη σε ασθενείς μετά από αορτοστεφανιαία παράκαμψη. University of Thessaly (UTH), 2017. http://hdl.handle.net/10442/hedi/42349